Respiratory syncytial virus (RSV) is an Orthopneumovirus that infects the epithelium of the
airways. Severe RSV infection of the lower respiratory tract in infants is a leading cause of …

US11324816B2 - Human respiratory syncytial virus (HRSV) virus-like particles (VLPS)
based vaccine - Google Patents US11324816B2 - Human respiratory syncytial virus (HRSV) …

Respiratory syncytial virus (RSV), a ubiquitous human pathogen, infects nearly all children
by the age of two. It produces severe lower respiratory tract disease, including bronchiolitis …

Human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract
infections in newborns, young children, and the elderly; causing significant morbidity and …

Coinfections with more than one respiratory virus can enhance or inhibit virus growth
kinetics and disease severity depending on the underlying mechanism of interaction …

Introduction: Human respiratory syncytial virus (RSV) causes a high rate of morbidity and
mortality worldwide in children, immunocompromised and elderly people. There is an urgent …

Acute lower respiratory infection (ALRI) remains as a leading cause of childhood morbidity
and mortality. With the continued universal vaccination campaign against bacterial …

the present disclosure includes strategies and methods used for the development of novel
VLPs-based vaccine system able to protect humans against infection with different hRSV …

Asthma is a complex inflammatory disease of the lung characterised by recurrent airflow
obstruction, wheezing, airway inflammation, and airway hyperresponsiveness (AHR)[76] …

2. SUMMARY 1 Background: Pregnant women and infants under 6 months old are at risk of
influenza-related 2 complications. Limited community-based data exists on the burden of …